Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LAR
3876
Lithium Argentina AG
LAR
$1.14B
| $214K | ﹤0.01% |
65,252
+17,649
| +37% | +$49K |
|
|
NINE
3877
DELISTED
Nine Energy Service
NINE
| $214K | ﹤0.01% |
188,949
+23,742
| +14% | +$33.8K |
|
|
LUMO
3878
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $213K | ﹤0.01% |
55,148
+4,421
| +9% | +$12.2K |
|
|
BHAC
3879
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
| $213K | ﹤0.01% |
20,185
-80
| -0.4% | -$866 |
|
3880
KALA BIO
KALA
$14.5M
| $212K | ﹤0.01% |
742
+364
| +96% | +$115K |
|
3881
VirnetX Holding Corp
VHC
$63.1M
| $211K | ﹤0.01% |
29,939
+1,662
| +6% | +$11K |
|
3882
POSCO
PKX
$17.5B
| $211K | ﹤0.01% |
3,016
-681
| -18% | -$44.5K |
|
3883
StealthGas
GASS
$319M
| $211K | ﹤0.01% |
30,948
| – | – |
|
|
SOWG
3884
Sow Good
SOWG
$54.9M
| $211K | ﹤0.01% |
1,201
-631
| -34% | -$149K |
|
3885
Tiziana Life Sciences
TLSA
$127M
| $210K | ﹤0.01% |
218,681
-840
| -0.4% | -$848 |
|
3886
Live Ventures
LIVE
$29.6M
| $210K | ﹤0.01% |
13,555
+330
| +2% | +$6.06K |
|
|
USBC
3887
USBC Inc
USBC
$132M
| $210K | ﹤0.01% |
18,286
+5,445
| +42% | +$71.4K |
|
3888
Stabilis Solutions
SLNG
$87.2M
| $209K | ﹤0.01% |
44,159
+3,429
| +8% | +$14.1K |
|
3889
Surrozen
SRZN
$301M
| $209K | ﹤0.01% |
17,761
-947
| -5% | -$8.36K |
|
3890
Aligos Therapeutics
ALGS
$34.9M
| $208K | ﹤0.01% |
24,056
+7,828
| +48% | +$97.4K |
|
|
ACTU
3891
Actuate Therapeutics
ACTU
$26.3M
| $208K | ﹤0.01% |
+27,893
| New | +$221K |
|
3892
Texas Community Bancshares
TCBS
| $208K | ﹤0.01% |
14,026
+1,285
| +10% | +$18.3K |
|
3893
CXApp
CXAI
$17.5M
| $207K | ﹤0.01% |
123,312
+26,764
| +28% | +$55.7K |
|
|
AIFC
3894
AI Financial Corp
AIFC
$61.3M
| $207K | ﹤0.01% |
116,799
+61,746
| +112% | +$126K |
|
3895
ImmuCell
ICCC
$99.5M
| $206K | ﹤0.01% |
56,660
+962
| +2% | +$3.74K |
|
|
GORV
3896
DELISTED
Lazydays
GORV
| $203K | ﹤0.01% |
4,504
+72
| +2% | +$4.89K |
|
3897
Marker Therapeutics
MRKR
$18.7M
| $202K | ﹤0.01% |
71,561
+3,319
| +5% | +$13.1K |
|
3898
Sypris Solutions
SYPR
$46.7M
| $201K | ﹤0.01% |
125,793
+20,612
| +20% | +$34.7K |
|
|
GMEX
3899
GMEX Robotics
GMEX
$1.12M
| $201K | ﹤0.01% |
2
| – | – |
|
|
PVLA
3900
Palvella Therapeutics
PVLA
$2.27B
| $201K | ﹤0.01% |
11,981
+1,358
| +13% | +$19.8K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.